Index of reports
> Death (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cabergoline death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cabergoline side effects in
Reported by a physician from United States on 2012-04-06
Patient:
Reactions: Caesarean Section, Maternal Drugs Affecting Foetus, Premature Separation of Placenta
Adverse event resulted in: death
Drug(s) suspected as cause:
Cabergoline
Possible Cabergoline side effects in 77 year old male
Reported by a physician from Japan on 2011-12-02
Patient: 77 year old male, weighing 47.0 kg (103.4 pounds)
Reactions: Pleural Fibrosis, Pulmonary Fibrosis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cabergoline
Other drugs received by patient: Estazolam; Opalmon; Almarl; Menest; Etodolac
Possible Cabergoline side effects in 50 year old male
Reported by a individual with unspecified qualification from United States on 2011-12-02
Patient: 50 year old male
Reactions: Dysphagia, Post Procedural Complication, Hyperglycaemia, Pituitary Tumour, Small Cell Carcinoma, Cushing's Syndrome, Metastases To Spine, Secondary Hypogonadism, Cranial Nerve Paralysis, Hypertension, Neuroendocrine Tumour, Metastases To Bone
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Octreotide Acetate
Dosage: 900 mcg (300 mcg,3 in 1 d),subcutaneous
Indication: Blood Corticotrophin Increased
Metyrapone (Metyrapone)
Dosage: 500 mg (250 mg,2 in 1 d),oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cabergoline
Dosage: 0.4286 mg (1.5 mg,2 in 1 wk)
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Cisplatin; Etoposide; Capecitabnie (Capecitabine); Temozolamide (Temozolamide); Rosiglitazone
Possible Cabergoline side effects in 77 year old male
Reported by a physician from Japan on 2011-11-18
Patient: 77 year old male
Reactions: Pulmonary Fibrosis, Pleural Fibrosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cabergoline
Possible Cabergoline side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10
Patient: 50 year old male
Reactions: Neoplasm Progression, Skin Hyperpigmentation, Headache, Death, Fatigue, Aspiration, Eye Movement Disorder, Back Pain, Pupillary Reflex Impaired, Dysphagia, Hyperglycaemia, Muscular Weakness, Hypoaesthesia, Hemianopia, Blood Corticotrophin Increased, Areflexia, Cortisol Free Urine Increased, Memory Impairment, Anosmia, Metastases To Bone
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Octreotide Acetate
Dosage: 300 ug, tid
Cabergoline
Dosage: 0.5 mg, twice a week
Administration route: Oral
Metyrapone
Dosage: 250 mg, bid
Administration route: Oral
Octreotide Acetate
Dosage: 300 ug, tid
Indication: Blood Corticotrophin Increased
Other drugs received by patient: Rosiglitazone; Capecitabine; Cisplatin; Temozolomide; Etoposide
Possible Cabergoline side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10
Patient: 50 year old male
Reactions: Neoplasm Progression, Skin Hyperpigmentation, Headache, Death, Fatigue, Aspiration, Eye Movement Disorder, Pupillary Reflex Impaired, Back Pain, Dysphagia, Hyperglycaemia, Muscular Weakness, Hypoaesthesia, Hemianopia, Blood Corticotrophin Increased, Cortisol Free Urine Increased, Areflexia, Memory Impairment, Anosmia, Metastases To Bone
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Octreotide Acetate
Dosage: 300 ug, tid
Octreotide Acetate
Dosage: 300 ug, tid
Indication: Blood Corticotrophin Increased
Metyrapone
Dosage: 250 mg, bid
Administration route: Oral
Cabergoline
Dosage: 0.5 mg, twice a week
Administration route: Oral
Other drugs received by patient: Capecitabine; Temozolomide; Cisplatin; Etoposide; Rosiglitazone
|